Last reviewed · How we verify

NCT04416152

Impact of Female Pelvic Reconstruction Surgery on Lower Urinary Tract Symptoms, Psychosomatic Distress and Sexual Function

Status unknown Last updated 15 September 2023
What this trial tests

trial testing Pelvic reconstruction surgery in Pelvic Organ Prolapse in 100 participants. Status unknown.

Timeline
26 May 2020
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorFar Eastern Memorial Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date26 May 2020
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Far Eastern Memorial Hospital

Who can join

20 and older, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To get the impact of pelvic floor reconstruction surgery on lower urinary tract symptoms, psychological distress and sexual function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Far Eastern Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04416152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing